What is the Triple Screening Test?
The triple screening test is a test conducted during pregnancy and is generally used to assess genetic abnormalities such as Down syndrome. This test helps evaluate pregnancy risks by measuring specific proteins and hormone levels in the expectant mother's blood.
The triple screening test gets its name from three different measurements:
1. Alpha-fetoprotein (AFP)
2. Beta-human chorionic gonadotropin (beta-hCG)
3. Estriol
The results obtained by measuring these three parameters are used to evaluate risks such as Down syndrome and other genetic abnormalities. The test is usually conducted between the 15th and 20th weeks of pregnancy. The determined risk level is generally based on the expectant mother's age, measured protein levels, and sometimes findings from ultrasound examinations.
The triple screening test typically provides a risk value, and for high-risk pregnancies, more detailed examinations or advanced tests may be recommended. However, this test is not for making a definitive diagnosis but rather for identifying potential risks. Therefore, evaluating the test results and consulting with a specialist doctor or genetic counselor is important when necessary.
How is the Triple Screening Test Done?
The triple screening test is usually performed during pregnancy between the 15th and 20th weeks and is aimed at evaluating the risk of genetic abnormalities like Down syndrome. Here are the stages of this test:
1. Blood Sample Collection:
The initial step required for the test is to collect a blood sample from the expectant mother. This usually occurs between the 15th and 20th weeks of pregnancy.
2. Measurement of Specific Proteins and Hormones:
The collected blood sample is analyzed in a laboratory. At this stage, the levels of specific proteins and hormones such as alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (beta-hCG), and estriol are measured.
3. Determining the Risk Level:
The measured levels of proteins and hormones are used to create a risk value based on the expectant mother's age, determinants in the test results, and sometimes findings from ultrasound examinations. As a result of this assessment, the risk level for Down syndrome and other genetic abnormalities in the pregnancy is determined.
4. Evaluation of Results and Progress:
Test results are generally presented as a risk level. Further examination, ultrasound, or advanced genetic tests might be suggested for high-risk pregnancies. However, it's essential to note that these tests are not for making a definitive diagnosis but to identify potential risks. Therefore, evaluating the results and consulting with a specialist doctor or genetic counselor when necessary is recommended.
The triple screening test is typically used during pregnancy to identify potential risks and guide further examinations or tests if needed. It's not for making a definite diagnosis but rather serves as an important screening tool to determine potential risks. Therefore, it's advisable to evaluate the results with a specialist doctor or genetic counselor.
What Are the Risks of the Triple Screening Test?
The triple screening test is generally conducted to evaluate conditions such as Down syndrome and some genetic abnormalities during pregnancy.
Although the triple screening test serves as a tool for determining risks, it is not for making a definite diagnosis but rather to identify potential risks. Therefore, when evaluating test results, it's important to consult with a specialist doctor or genetic counselor. These professionals can provide better insight into the test results and guidance on further tests or treatment options if necessary.